15 January 2025 [Comunicado de prensa]

Announcement of the Cooperation Between DiagCor Life Science Ltd. (DiagCor) and Precision System Science Co., Ltd. (PSS)

DiagCor Life Science Ltd. (DiagCor) is pleased to announce a close collaboration with Precision System Science Co., Ltd. (PSS). PSS is a market leader in automated DNA extraction, as demonstrated by its patented Magtration^® technology, and over 40 years of experience in laboratory automation. DiagCor has already been working with PSS products for several years, combining PSS’s magLEAD nucleic acid extraction systems with DiagCor’s GenoFlow^TM and GenoScreen CE-IVD product lines for specific applications in selected territories.

During the new phase of cooperation, both companies will extend the scope to include PSS’s geneLEAD VIII, an All-in-One, fully automated Sample-to-Result system. This instrument combines a compact footprint and ease of use with high performance and reliability, employing a series of efficient straight-line prefilled plastics disposables for extraction and PCR, ensuring maximum convenience while minimizing contamination. It features the magLEAD’s globally recognized, reliable nucleic acid extraction technology, together with 6-color fluorescence detection, independent temperature control for up to 8 samples, UV lamp and HEPA filter, LIS connectivity, and is an open system that accepts any kind of PCR reagents. For more details on the operational workflow of the geneLEAD VIII system, please refer to the following video.

To target the clinical market, DiagCor aims to develop and optimise selected high-performance real-time PCR kits, along with the geneLEAD VIII fully automated system, to benefit IVD professionals. For more details, please contact our sales team at [email protected].

About DiagCor: Headquartered in Hong Kong with ISO 13485 accredited Quality Management System (QMS), DiagCor has been a pioneer in multiplex technologies via its global leader in Flow-through hybridization instruments and GenoFlow^TM assays, and is now growing an extensive portfolio of qPCR assays for in vitro diagnostics on open systems, covering the areas of infectious disease, oncology and human genetics.

About PSS: Headquartered in Chiba, Japan, PSS develops instruments for in vitro diagnostics. In addition to a proprietary, fully automated nucleic acid isolation system, the company offers multi-purpose magnetic bead-based open-platform instruments, including ready-to-use sample-to-results systems.